Selective cytotoxicity of ponciri fructus against glucose-deprived PANC-1 human pancreatic cancer cells via blocking activation of GRP78

Bioscience, Biotechnology and Biochemistry

Volumn 73, Issue 10, 2009, Pages 2167-2171

  Cha, Mi Ran ^a   Yoon, Mi Young ^a   Son, Eun Soon ^a   Park, Hae Ryong ^a  

^a Kyungnam University   (South Korea)

Author keywords

Glucose deprivation; GRP78; Pancreatic cancer; Ponciri fructus; Unfolded protein response

Indexed keywords

GLUCOSE DEPRIVATION; GRP78; PANCREATIC CANCER; PONCIRI FRUCTUS; UNFOLDED PROTEIN RESPONSE;

CELL DEATH; CELL MEMBRANES; GLUCOSE; TUMORS;

CYTOTOXICITY;

ANTINEOPLASTIC AGENT; GLUCOSE; HEAT SHOCK PROTEIN; MOLECULAR CHAPERONE GRP78; PLANT EXTRACT;

APOPTOSIS; ARTICLE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; GLUCOSE; HEAT-SHOCK PROTEINS; HUMANS; PANCREATIC NEOPLASMS; PLANT EXTRACTS;

EID: 70350442250     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.90235     Document Type: Article

References (23)

1. Nichols MT, Russ PD, and Chen YK, Pancreas, 33, 211-220 (2006).
2. Guha S, Lunn JA, Santiskulvong C, and Rozengurt E, Cancer Res., 63, 2379-2387 (2003).
3. Kleeff J, Michalski C, Friess H, and Buchler MW, Pancreas, 33, 111-118 (2006).
4. Yeh JJ and Der CJ, Expert Opin. Ther. Targets, 11, 673-694 (2007).
5. Von Hoff DD, Best Pract. Res. Clin. Gastroentrol., 20, 315-326 (2006).
6. Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, and Esumi H, Cancer Res., 66, 1751-1757 (2006).
7. Kokkinakis DM, Liu XY, and Neuner RD, Mol. Cancer Ther., 4, 1338-1348 (2005).
8. Izuishi K, Kato K, Ogura T, Kinoshita T, and Esumi H, Cancer Res., 60, 6201-6207 (2000).
9. Ogiso Y, Tomida A, Kim HD, and Tsuruo T, Biochem. Biophys. Res. Commun., 258, 448-452 (1999).
10. Ogiso Y, Tomida A, Lei S, Omura S, and Tsuruo T, Cancer Res., 60, 2429-2434 (2000).
11. Park HR, Tomida A, Sato S, Tsukumo Y, Yun J, Yamori T, Hayakawa Y, Tsuruo T, and Shin-ya K, J. Natl. Cancer Inst., 96, 1300-1310 (2004).
12. Luo S, Baumeister P, Yang S, Abcouwer SF, and Lee AS, J. Biol. Chem., 278, 37375-37385 (2003).
13. Feldman DE, Chauhan V, and Koong AC, Mol. Cancer Res., 3, 597-605 (2005).
14. Park HR, Ryoo IJ, Choo SJ, Hwang JH, Kim JY, Cha MR, Shin-ya K, and Yoo ID, Toxicology, 229, 253-261 (2007).
15. Li J and Lee AS, Curr. Mol. Med., 6, 45-54 (2006).
16. Hets C, Bernasconi P, Fisher J, Lee AH, Bassik MC, Antocsson B, Brandt GS, Iwakoshi NN, Schinzel A, Glimcher LH, and Korsmeyer SJ, Science, 312, 572-576 (2006).
17. Zhang K and Kaufman RJ, J. Biol. Chem., 279, 25935-25938 (2004).
18. Kadowaki H, Nishitoh H, and Ichijo H, J. Chem. Neuroanat., 28, 93-100 (2004).
19. Tomida A and Tsuruo T, Anticancer Drug Des., 14, 169-177 (1999).
20. Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, and Haga N, Cancer Sci., 94, 15-21 (2003).
21. Fu Y and Lee AS, Cancer Biol. Ther., 5, 741-744 (2006).
22. Lee AS, Trends Biochem. Sci., 26, 504-510 (2001).
23. Sausville EA, J. Natl. Cancer Inst., 96, 1266-1267 (2004).